We are live on ! Find out more
WHWK

Whitehawk Therapeutics
WHWK

40 hedge funds and large institutions have $19.4M invested in Whitehawk Therapeutics in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 5

21% more funds holding

Funds holding: 33 → 40 (+7)

11% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 9

0.03% more ownership

Funds ownership: 2.76% → 2.8% (+0.03%)

26% less capital invested

Capital invested by funds: $26.1M → $19.4M (-$6.71M)

Holders
40
Holders Change
+7
Holders Change %
+21.21%
% of All Funds
0.71%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
12
Increased
10
Reduced
9
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.19M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$469K
3
Renaissance Technologies
Renaissance Technologies
New York
+$447K
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$356K
5
VF
Virtu Financial
New York
+$191K

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$4.94M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.81M
3
BFM
Boothbay Fund Management
New York
-$521K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$266K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$241K
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
26
Russell Investments Group
United Kingdom
$20K – – –
Jane Street
27
Jane Street
New York
$20K +$21 +1 +0.1%
GCP
28
GSA Capital Partners
United Kingdom
$18K +$25.5K +1,193 New
BW
29
Bison Wealth
Georgia
$17K – – –
Charles Schwab
30
Charles Schwab
California
$13K – – –
SSA
31
Schonfeld Strategic Advisors
New York
$12K +$17K +793 New
SFI
32
Susquehanna Fundamental Investments
Pennsylvania
$11K +$15.7K +733 New
AWP
33
Ascent Wealth Partners
New York
$10K – – –
TI
34
Truepoint Inc
Ohio
$10K +$14.6K +681 New
TRCT
35
Tower Research Capital (TRC)
New York
$3K +$984 +46 +25%
LC
36
Lindbrook Capital
California
$2K -$39.7K -1,855 -93%
Osaic Holdings
37
Osaic Holdings
Arizona
$1K -$86 -4 -4%
Wells Fargo
38
Wells Fargo
California
$1K +$706 +33 +69%
Two Sigma Advisers
39
Two Sigma Advisers
New York
– -$241K -10,727 Closed
Millennium Management
40
Millennium Management
New York
– -$89 -3,972 Closed
Two Sigma Investments
41
Two Sigma Investments
New York
– -$59K -2,633 Closed
CL
42
CSS LLC
Illinois
– -$45K -2,000 Closed
JP Morgan Chase
43
JP Morgan Chase
New York
– -$10K -427 Closed
PA
44
Parallel Advisors
California
– +$171 +8 New
OSAM
45
O'Shaughnessy Asset Management
Connecticut
– +$321 +15 New
1
2

WHWK Hedge Fund Activity: Q4 2020 in Review

40 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q4 2020, worth a combined $19.4M — down 26% from $26.1M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new WHWK positions and 5 closed out — a net gain of 7 holders — while 10 added to existing stakes and 9 trimmed.

The largest buyer was Vanguard Group, adding an estimated $2.19M. The largest seller was Ikarian Capital, cutting an estimated $4.94M.

  • 40 institutional investors held Whitehawk Therapeutics (WHWK) as of Q4 2020, up from 33 in Q3 2020.
  • Funds reported $19.4M of Whitehawk Therapeutics stock for Q4 2020, down 26% quarter-over-quarter.
  • 12 funds opened new Whitehawk Therapeutics positions in Q4 2020 and 5 closed out, a net change of +7 holders.
  • The largest Whitehawk Therapeutics buyer in Q4 2020 was Vanguard Group, an estimated $2.19M added.
  • The largest Whitehawk Therapeutics seller in Q4 2020 was Ikarian Capital, an estimated $4.94M sold.

Based on aggregated 13F filings for Q4 2020.